AAAAAA

   
Results: 1-16 |
Results: 16

Authors: LIEBERMAN JA SHEITMAN B CHAKOS M ROBINSON D SCHOOLER N KEITH S
Citation: Ja. Lieberman et al., THE DEVELOPMENT OF TREATMENT RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA - A CLINICAL AND PATHOPHYSIOLOGIC PERSPECTIVE, Journal of clinical psychopharmacology, 18(2), 1998, pp. 20-24

Authors: GOLDMAN RS BATES JA PAPPADOPULOS E BILDER RM BORENSTEIN M KANE J SCHOOLER N MARDER S
Citation: Rs. Goldman et al., EFFECTS OF CLOZAPINE AND HALOPERIDOL ON EXPLICIT MEMORY IN TREATMENT-REFRACTORY PATIENTS, Schizophrenia research, 24(1-2), 1997, pp. 104-104

Authors: SCHOOLER N BORENSTEIN M AMES D BAKER R UMBRICHT D WIRSHING W KANE J MARDER S
Citation: N. Schooler et al., FIRST IMPROVEMENT WITH CLOZAPINE - HOW PATIENT SHOULD WE BE, Schizophrenia research, 24(1-2), 1997, pp. 188-188

Authors: UMBRICHT D AMES D WIRSHING WC BAKER R CHENGAPPA R BORENSTEIN M SCHOOLER N MARDER S KANE J
Citation: D. Umbricht et al., PREDICTORS OF RESPONSE TO CLOZAPINE IN A LONG-TERM DOUBLE-BLIND TREATMENT STUDY, Schizophrenia research, 24(1-2), 1997, pp. 189-189

Authors: AHMED S SCHOOLER N MONTROSE D HAAS G SWEENEY J KESHAVAN MS
Citation: S. Ahmed et al., EFFICACY OF RISPERIDONE IN FIRST-EPISODE SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 193-193

Authors: WIRSHING WC BAKER R UMBRICHT D AMES D SCHOOLER N KANE J MARDER SR BORENSTEIN D
Citation: Wc. Wirshing et al., CLOZAPINE VS HALOPERIDOL - DRUG INTOLERANCE IN A CONTROLLED 6 MONTH TRIAL, Schizophrenia research, 24(1-2), 1997, pp. 268-268

Authors: BEASLEY CM SANGER T SATTERLEE W TOLLEFSON G TRAN P HAMILTON S GREEN A DOTT S PFISTER G ROXAS L SMALL J THOMAS M AMES D SCHOOLER N BAKER R LEVINE R FABRE L FRIEDEL R SAFFERMAN A LIEBERMAN J STAHL S
Citation: Cm. Beasley et al., OLANZAPINE VERSUS PLACEBO - RESULTS OF A DOUBLE-BLIND, FIXED-DOSE OLANZAPINE TRIAL, Psychopharmacology, 124(1-2), 1996, pp. 159-167

Authors: GOLDMAN RS BATES JA BILDER RM KANE J SCHOOLER N MARDER S
Citation: Rs. Goldman et al., THE EFFECTS OF CLOZAPINE AND HALDOL ON MEMORY FUNCTIONING IN TREATMENT-REFRACTORY SCHIZOPHRENICS, Schizophrenia research, 18(2-3), 1996, p.

Authors: HERZ M FRANCES R LIEBERMAN J SCHOOLER N GOLDMAN H
Citation: M. Herz et al., MAJOR ADVANCES IN THE TREATMENT OF SCHIZOPHRENIA - DISCUSSION, Psychiatric annals, 26(8), 1996, pp. 536-538

Authors: KESHAVAN MS KISLER T ROSENBERG D BAGWELL W SWEENEY J HAAS G SCHOOLER N PETTEGREW J
Citation: Ms. Keshavan et al., DECREASED CAUDATE VOLUME IN FIRST EPISODE SCHIZOPHRENIA, Biological psychiatry, 39(7), 1996, pp. 197-197

Authors: CARTER CS BARCH D PEARLSTEIN W BAIRD J BAKER R COHEN JD SCHOOLER N
Citation: Cs. Carter et al., A COGNITIVE NEUROPSYCHOLOGICAL STUDY OF SCHIZOPHRENIA SYMPTOMS - CORRELATES OF STROOP AND SEMANTIC PRIMING PERFORMANCE, Schizophrenia research, 15(1-2), 1995, pp. 111-112

Authors: SCHOOLER N KANE J MARDER S BAKER R SAFFERMAN A WIRSHING W AMES D GANGULI R UMBRICHT D BORENSTEIN M
Citation: N. Schooler et al., EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY FINDINGS, Schizophrenia research, 15(1-2), 1995, pp. 165-165

Authors: CARTER C BARCH D PEARLSTEIN W BAIRD J BAKER R COHEN J SCHOOLER N
Citation: C. Carter et al., SINGLE TRIAL STROOP VERSUS STROOP CARD MEASUREMENTS IN SCHIZOPHRENIA, Biological psychiatry, 37(9), 1995, pp. 637-637

Authors: CARTER C BARCH D PEARLSTEIN W BAIRD J BAKER R COHEN J SCHOOLER N
Citation: C. Carter et al., ATTENTION, SEMANTIC PROCESSING, AND SYMPTOMS IN SCHIZOPHRENIA, Biological psychiatry, 37(9), 1995, pp. 638-638

Authors: AMES D WIRSHING WC KANE J SCHOOLER N MARDER SR BAKER R SAFFERMAN A GANGULI R UMBRICHT D BORENSTEIN M
Citation: D. Ames et al., EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY-RESULTS, Biological psychiatry, 37(9), 1995, pp. 661-661

Authors: DAVIS JM KANE JM MARDER SR BRAUZER B GIERL B SCHOOLER N CASEY DE HASSAN M
Citation: Jm. Davis et al., DOSE-RESPONSE OF PROPHYLACTIC ANTIPSYCHOTICS, The Journal of clinical psychiatry, 54, 1993, pp. 24-30
Risultati: 1-16 |